Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Pennsylvania for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Pennsylvania only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Pennsylvania (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Danielle Young (NPI 1578196457)

Field	Value
Entity Type	Individual
Organization	Danielle Young
Address	70 E Swedesford Rd Ste 130
City	Malvern
State	PA
ZIP	19355
Taxonomy	Family Nurse Practitioner
NPI Enumerated	February 19, 2020

Payer Source	Total Paid
Medicare	$3.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer in the dataset: lifetime Medicare revenue is $3.7M and there is no Medicaid billing on file. The absence of Medicaid claims means analyses of Medicaid risk, access, or state-level payer mix are not possible for this entity and Medicare drives the full observed revenue footprint.

Revenue is highly concentrated in a small number of drugs and administration codes: the precomputed top‑3 Medicare codes account for 69.4% of this provider's total Medicare revenue. The top three codes driving that concentration are J3245 ($1.4M; 39.1%), J9332 ($775K; 21.0%), and J0517 ($343.1K; 9.3%), indicating most dollars come from a narrow set of biologic therapies.

The code mix is dominated by high‑cost injectable biologics and infusion administration codes (multiple J‑codes and infusion CPTs), which suggests the practice operation focuses on in‑office administration of specialty biologic therapies rather than routine primary care office visits. Presence of J3245, J0517, J2350, J1306 and other J‑codes, together with infusion/administration codes like 96413 and 96365, supports a service line built around drug administration and infusion workflows.

J3245 is a standout by utilization and revenue: the provider reported $1.4M on J3245 (39.1% of Medicare revenue) and ranks #8 of 225 providers nationally, described as notably above typical national volume for this code. That single code is the largest revenue driver and places the provider among the upper echelon of billers nationwide for tildrakizumab administration.

Competitive standing across other high‑value codes is mixed: J0517 ($343.1K) ranks #28 of 200 (86th percentile) and J1306 ($253K) ranks #40 of 462 (92th percentile) yet both are labeled as typical, unremarkable volume for their codes; J9332 ($775K) is reported as typical, unremarkable volume despite a small national provider pool (rank #4 of 5). In short, the provider is a major national performer on at least one key biologic (J3245) but shows more typical participation on several other specialty injectable codes.

There are notable outlier signals in administration/injection services: 96372 has 647 claims and is listed as notably above typical national volume (rank #1026 of 58224; 98th percentile), indicating frequent use of intramuscular/subcutaneous injection procedures beyond the primary biologics. At the same time, chemotherapy/infusion codes such as 96413 (178 claims) and 96365 (115 claims) appear at much smaller revenue shares, suggesting occasional infusion activity rather than a full oncology infusion service line.

From a payer perspective, the heavy reliance on a few biologic J‑codes creates concentrated spend exposure because a small number of therapies (and their administration) account for most Medicare dollars. Given the top‑3 concentration at 69.4% and the single‑code share of 39.1% for J3245, payers should note that any changes in utilization, pricing, or site‑of‑care for those drugs would disproportionately affect total spend with this provider.

Provider tenure is moderate: the NPI was enumerated on 2020-02-19 (~6 years ago). This timeframe is sufficient to have established regular billing patterns for specialty injectables and suggests the current code mix and concentration are not just a very recent anomaly but part of a multi‑year billing profile.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	13,100	$110	$1.4M
J9332	Injection, efgartigimod alfa-fcab, 2mg	31,000	$30	$775K
J0517	Injection, benralizumab, 1 mg	2,580	$130	$343.1K
J2350	Injection, ocrelizumab, 1 mg	7,200	$50	$338.4K
J1306	Injection, inclisiran, 1 mg	28,120	$10	$253K
J2182	Injection, mepolizumab, 1 mg	7,200	$20	$165.6K
J2356	Injection, tezepelumab-ekko, 1 mg	10,500	$10	$147K
J2357	Injection, omalizumab, 5 mg	4,170	$30	$125.1K
J0897	Injection, denosumab, 1 mg	1,980	$20	$35.6K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	1,240	$30	$32.2K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Pennsylvania Distribution

Danielle Young — 1 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Pennsylvania

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9332	1	10	31,000	$20	$772.2K
J3245	2	10	3,750	$110	$670.1K
J2350	2	10	7,650	$50	$346.4K
J0517	5	10	1,560	$130	$276.6K
J2357	20	30	6,810	$30	$239.4K
J2182	3	10	4,550	$20	$172.9K
J2356	2	10	7,770	$10	$166.7K
J1306	2	20	8,800	$10	$155K
J1745	60	80	3,630	$30	$115.4K
J0897	308	530	2,460	$20	$89.6K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Danielle Young, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Stacey Godman	MA	Nurse Practitioner	$1.7M	$0
Caitlin Trainor	PA	Family Nurse Practitioner	$1.3M	$0
Priti Patel	PA	Family Nurse Practitioner	$900.3K	$0
Danielle Boyle	PA	Family Nurse Practitioner	$411.3K	$0
Jeanne-marie Firpo	NY	Nurse Practitioner	$210.9K	$0
Prasant Pandey	PA	Cardiovascular Disease Physician	$122.3K	$0

Nearby Providers

Other providers in the same ZIP code as Danielle Young, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Malvern Institute For Psychiatric And Alcoholic Studies, Inc.	PA	Special Hospital	$0	$91.7M
Cardionet, LLC	PA	Physiological Laboratory	$11M	$63.2M
Childrens Surgery Center Of Malvern, LLC	PA	Ambulatory Surgical Clinic/Center	$0	$11.3M
Ramsis Holdings, Hands From The Heart Home Healthcare Services	PA	Home Health Agency	$0	$8.3M
Coram Alternate Site Services Inc	PA	Home Infusion Therapy Pharmacy	$54.7K	$2.6M
Jennifer Kwan-morley	PA	Rheumatology Physician	$2.5M	$0
Main Line PA Endoscopy Asc LP	PA	Ambulatory Surgical Clinic/Center	$1.1M	$0
Stephanie Morris	PA	Rheumatology Physician	$742.6K	$0
Jeffrey Rihn	PA	Orthopaedic Surgery Physician	$472.1K	$0
Jonathan Garino	PA	Orthopaedic Surgery Physician	$243.4K	$0

Danielle Young — Billing Profile & Reimbursement Data

Sign up for Danielle Young — Billing Profile & Reimbursement Data policy alerts

Danielle Young — Billing Profile & Reimbursement Data

Sign up for Danielle Young — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References